Aggarwal, P., Bone, R., Nwotchouang, B., Moffett, N., Jennings-Zhang, L., Chedid, S., Baljevic, M., Feinberg, B. (2025). Physicians perceptions of fixed-duration epcoritamab + lenalidomide and rituximab regimens in relapsed/refractory follicular lymphoma: Insights from the epcore NHL-2 trial. Blood. https://doi.org/10.1182/blood-2025-7938